The Use and Impact of a Decision Support Tool for Appendicitis Treatment

Author:

,Rosen Joshua E.1,Monsell Sarah E.2,DePaoli Sara C.1,Fannon Erin C.1,Kohler Johnathan E.3,Reinke Caroline E.4,Kao Lillian S.5,Fransman Ryan B.6,Stulberg Jonah J.7,Shapiro Michael B.8,Nehra Deepika9,Park Pauline K.10,Sanchez Sabrina E.11,Fischkoff Katherine N.12,Davidson Giana H.13,Flum David R.1

Affiliation:

1. Department of Surgery, University of Washington, Seattle, WA

2. Department of Biostatistics, University of Washington, Seattle, WA

3. University of California, Davis, UC Davis Children’s Hospital, Sacramento, CA

4. Atrium Health, Charlotte, NC

5. UTHealth Houston, Houston, TX

6. Grady Health Center/Morehouse School of Medicine, SE, Atlanta, Georgia

7. Lyndon B Johnson Hospital, Houston, TX

8. Northwestern Medicine, Chicago, IL

9. Department of Surgery, Harborview Medical Center, University of Washington, Seattle WA

10. Michigan Medicine, Ann Arbor, MI

11. Boston Medical Center, Boston, MA

12. Columbia University Medical Center, Columbia University Medical Center Research Office, New York, NY

13. Department of Surgery, University of Washington, SORCE, Seattle, WA

Abstract

Objective: Since introducing new and alternative treatment options may increase decisional conflict, we aimed to describe the use of the decision support tool (DST) and its impact on treatment preference and decisional conflict. Background: For the treatment of appendicitis, antibiotics are an effective alternative to appendectomy, with both approaches associated with a different set of risks (eg, recurrence vs surgical complications) and benefits (eg, more rapid return to work vs decreased chance of readmission). Patients often have limited knowledge of these treatment options, and DSTs that include video-based educational materials and questions to elicit patient preferences about outcomes may be helpful. Concurrent with the Comparing Outcomes of Drugs and Appendectomy trials, our group developed a DST for appendicitis treatment (www.appyornot.org). Methods: A retrospective cohort including people who self-reported current appendicitis and used the AppyOrNot DST between 2021 and 2023. Treatment preferences before and after the use of the DST, demographic information, and Ottawa Decisional Conflict Scale (DCS) were reported after completing the DST. Results: A total of 8243 people from 66 countries and all 50 U.S. states accessed the DST. Before the DST, 14% had a strong preference for antibiotics and 31% for appendectomy, with 55% undecided. After using the DST, the proportion in the undecided category decreased to 49% (P < 0.0001). Of those who completed the Ottawa Decisional Conflict Score (DCS; n = 356), 52% reported the lowest level of decisional conflict (<25) after using the DST; 43% had a DCS score of 25 to 50, 5.1% had a DCS score of >50 and 2.5% had and DCS score of >75. Conclusions: The publicly available DST appyornot.org reduced the proportion that was undecided about which treatment they favored and had a modest influence on those with strong treatment preferences. Decisional conflict was not common after use. The use of this DST is now a component of a nationwide implementation program aimed at improving the way surgeons share information about appendicitis treatment options. If its use can be successfully implemented, this may be a model for improving communication about treatment for patients experiencing emergency health conditions.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference19 articles.

1. The answer is 17 years, what is the question: understanding time lags in translational research;Morris;J R Soc Med,2011

2. How long does biomedical research take? Studying the time taken between biomedical and health research and its translation into products, policy, and practice;Hanney;Health Res Policy Syst,2015

3. Managing yourself: a new approach to funding medical research;Kaplan;Harv Bus Rev,2019

4. The Financial Crisis and the Well-being of Americans, 2009;Deaton;Soc Sci Med,2012

5. Exploring the use of virtual reality in Parkinson’s disease rehabilitation: a systematic mapping review;Wieringa;J Parkinsons Dis,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3